Margrit Carlson

University Of California Los Angeles

$2,924,185

Attributed

$2,924,185

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$2,924,185 · 10

By mechanism

M01$2,924,185 · 10

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Judith S. Currier$525,401,794
Linda M Liau$8,990,878
James G Tidball$18,225,068
Caius Gabriel Radu$8,088,566
Z Hong Zhou$29,087,466

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchHiv InfectionsHuman SubjectHuman Therapy EvaluationAids TherapyDrug Screening /EvaluationAntiaids AgentAntiviral AgentsCombination ChemotherapyMicroorganism Disease ChemotherapyInjection /InfusionSynthetic PeptideIndinavirDrug Adverse EffectProtease InhibitorAidsClinical TrialsAntibody FormationClinical ChemistryFluconazoleCandidiasisHost Organism InteractionHuman Immunodeficiency VirusHematology

Grant awards (18)

A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF QUADRIVALENT: HIV$20,558

M01 · FY2009 · RR · contact PI

RANDOMIZED DOUBLE-BLIND PHASE II STUDY OF INDINAVIR SULFATE, DMP-266 AND 1592U$207,266